BUFFALO GROVE, Ill.--(BUSINESS WIRE)--March 28, 2006--Akorn, Inc. (AMEX:AKN) today announced that it has signed a Purchase and Supply Agreement with Natco Pharma Limited (NSE:NATCOPHARM)(BSE:524816), located in Hyderabad, India, to commercialize two ANDA oral drug products for cancer patients suffering from nausea and vomiting.
